Abstract
Get full access to this article
View all access options for this article.
References
1.
Buyse
M
Carter
S
Sarnataro
K.
Factors influencing the implementation of value-based contracting between pharmaceutical manufacturers and payers . J Clin Pathways . 2018 ;4 (4 ):27 -30 .
2.
Nazareth
T
Ko
JJ
Sasane
R
, et al . Outcomes-based contracting experience: research findings from U.S. and European stakeholders . J Manag Care Spec Pharm . 2017 ;23 :1018 -1026 .
3.The Economist Intelligence Unit . Value-based health assessment in Italy . https://eiuperspectives.economist.com/sites/default/files/Value-based%20Health%20Assessment%20in%20Italy.pdf. Accessed May 12, 2019 .
4.
Iskowitz
M.
Payer-pharma collaboration through value-based contracts is set to accelerate . https://www.mmm-online.com/home/channel/features/payer-pharma-collaboration-through-value-based-contracts-is-set-to-accelerate/. Published January 7, 2019. Accessed May 13, 2019 .
5.Managed Healthcare Executive . Novartis signs on to value-based pricing for Entresto . https://www.managedhealthcareexecutive.com/managed-healthcare-executive/news/novartis-signs-value-based-pricing-entresto. Published May 4, 2016. Accessed November 20, 2018 .
6.American Journal of Managed Care . Amgen sign outcomes-based contract for Reaptha . https://www.ajmc.com/focus-of-the-week/amgen-signs-outcomes-based-contract-for-repatha. Published May 5, 2017. Accessed November 19, 2018 .
7.
Duhig
AM
Saha
S
Smith
S
Kaufman
S
Hughes
J.
The current status of outcomes-based contracting for manufacturers and payers: an AMCP membership survey . J Manag Care Spec Pharm . 2018 ;24 :410 -415 .
8.Network for Excellence in Health Innovation . Value-based contracting for oncology drugs . https://www.nehi.net/writable/publication_files/file/nehi_vbconcology_final.pdf. Accessed October 9, 2018 .